UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants

The American journal of clinical nutrition, 2023-02, Vol.117 (2), p.326-339

2023

Volltextzugriff (PDF)

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

The Journal of infectious diseases, 2022-05, Vol.225 (10), p.1741-1749

2022

Volltextzugriff (PDF)

Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results

The Journal of infectious diseases, 2011-10, Vol.204 (8), p.1191-1201

2011

Volltextzugriff (PDF)

Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study

Clinical infectious diseases, 2018-05, Vol.66 (11), p.1712-1721

2018

Volltextzugriff (PDF)

Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e1893-e1900

2021

Volltextzugriff (PDF)

Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

Journal of antimicrobial chemotherapy, 2017-06, Vol.72 (6), p.1731-1740

2017

Volltextzugriff (PDF)

Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques

The Journal of infectious diseases, 2019-10, Vol.220 (11), p.1826-1833

2019

Volltextzugriff (PDF)

Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection

The Journal of infectious diseases, 2016-10, Vol.214 (7), p.1058-1062

2016

Volltextzugriff (PDF)

Murray's Balancing Act: The Harmony of Nature and Grace

A journal of church and state, 2016-09, Vol.58 (4), p.666-689

Rooney, James Dominic

2016

Volltextzugriff (PDF)

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

The Journal of infectious diseases, 2017-01, Vol.215 (2), p.238-246

2017

Volltextzugriff (PDF)

Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation

Clinical infectious diseases, 2021-08, Vol.73 (3), p.e643-e651

2021

Volltextzugriff (PDF)

Public Reason Naturalism

The American journal of jurisprudence (Notre Dame), 2024-03, Vol.68 (3), p.195-210

Rooney, James Dominic

2024

Volltextzugriff (PDF)

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention

The Journal of infectious diseases, 2022-12, Vol.226 (12), p.2170-2180

2022

Volltextzugriff (PDF)

No change in calculated creatinine clearance after tenofovir initiation among Thai patients

Journal of antimicrobial chemotherapy, 2007-05, Vol.59 (5), p.1034-1037

2007

Volltextzugriff (PDF)

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial

Clinical infectious diseases, 2015-08, Vol.61 (4), p.572-580

2015

Volltextzugriff (PDF)

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

Clinical infectious diseases, 2015-10, Vol.61 (7), p.1179-1188

2015

Volltextzugriff (PDF)

The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1-Infected Individuals

The Journal of infectious diseases, 2012-01, Vol.205 (1), p.87-96

2012

Volltextzugriff (PDF)

Once-Daily Quadruple-Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment-Naive Human Immunodeficiency Virus Type 1–Infected Patients

The Journal of infectious diseases, 2002-10, Vol.186 (7), p.1028-1033

2002

Volltextzugriff (PDF)

Efavirenz versus Boosted Atazanavir or Zidovudine and Abacavir in Antiretroviral Treatment-Naive, HIV-Infected Subjects: Week 48 Data from the Altair Study

Clinical infectious diseases, 2010-10, Vol.51 (7), p.855-864

2010

Volltextzugriff (PDF)

Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy

Clinical infectious diseases, 2013-07, Vol.57 (2), p.290-297

2013

Volltextzugriff (PDF)

Determining the Relative Efficacy of Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2003-03, Vol.187 (6), p.896-900

2003

Volltextzugriff (PDF)

Effect of Variation in the Burst and Carrier Frequency Modes of Neuromuscular Electrical Stimulation on Pain Perception of Healthy Subjects

Physical therapy, 1992-11, Vol.72 (11), p.800-00809

1992

Volltextzugriff (PDF)

Virologic and Immunologic Benefits of Initial Combination Therapy with Zidovudine and Zalcitabine or Didanosine Compared with Zidovudine Monotherapy

The Journal of infectious diseases, 1996-06, Vol.173 (6), p.1354-1366

1996

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Aktive Filter

KollektionOxford journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(49)
Humans
(35)
Infectious Diseases
(33)
Microbiology
(33)
Immunology
(28)
Female
(25)
Adult
(21)
Male
(20)
Biological And Medical Sciences
(18)
Medical Sciences
(17)
Hiv
(16)
Hiv Infections - Drug Therapy
(16)
Human Immunodeficiency Virus
(16)
Animals
(13)
Middle Aged
(13)
Infections
(10)
Tenofovir
(10)
Adenine - Analogs & Derivatives
(9)
Anti-Hiv Agents - Administration & Dosage
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants

Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results

Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study

Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa

Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques

Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection

Murray's Balancing Act: The Harmony of Nature and Grace

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation

Public Reason Naturalism

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention

No change in calculated creatinine clearance after tenofovir initiation among Thai patients

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel

The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1-Infected Individuals

Once-Daily Quadruple-Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment-Naive Human Immunodeficiency Virus Type 1–Infected Patients

Efavirenz versus Boosted Atazanavir or Zidovudine and Abacavir in Antiretroviral Treatment-Naive, HIV-Infected Subjects: Week 48 Data from the Altair Study

Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy

Determining the Relative Efficacy of Highly Active Antiretroviral Therapy

Effect of Variation in the Burst and Carrier Frequency Modes of Neuromuscular Electrical Stimulation on Pain Perception of Healthy Subjects

Virologic and Immunologic Benefits of Initial Combination Therapy with Zidovudine and Zalcitabine or Didanosine Compared with Zidovudine Monotherapy

Aktive Filter

Suchergebnisse filtern